Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment

Based on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively....

Full description

Bibliographic Details
Main Authors: V. B. Mychka, I. E. Chazova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2008-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1634
_version_ 1797882666056417280
author V. B. Mychka
I. E. Chazova
author_facet V. B. Mychka
I. E. Chazova
author_sort V. B. Mychka
collection DOAJ
description Based on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively. The medication is safe and metabolically neutral even when administered as a long-term treatment.
first_indexed 2024-04-10T03:39:24Z
format Article
id doaj.art-5bbefb4f767d4bb29aab3078f4fcfbf0
institution Directory Open Access Journal
issn 1728-8800
2619-0125
language Russian
last_indexed 2024-04-10T03:39:24Z
publishDate 2008-12-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj.art-5bbefb4f767d4bb29aab3078f4fcfbf02023-03-13T07:23:16Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252008-12-017656591351Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatmentV. B. Mychka0I. E. Chazova1Институт клинической кардиологии им. А.Л. Мясникова ФГУ “Российский кардиологический научно-производственный комплекс”, г. МоскваИнститут клинической кардиологии им. А.Л. Мясникова ФГУ “Российский кардиологический научно-производственный комплекс”, г. МоскваBased on the results of international clinical trials, the clinical benefits of a dihydropyridine calcium antagonist, nifedipine GITS (slow-release gastrointestinal therapeutic-system) are discussed. Nifedipine GITS has been demonstrated to reduce cardiovascular morbidity and mortality effectively. The medication is safe and metabolically neutral even when administered as a long-term treatment.https://cardiovascular.elpub.ru/jour/article/view/1634сердечно-сосудистые заболеванияантагонисты кальциянифедипин гитсэффективность и безопасность
spellingShingle V. B. Mychka
I. E. Chazova
Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
Кардиоваскулярная терапия и профилактика
сердечно-сосудистые заболевания
антагонисты кальция
нифедипин гитс
эффективность и безопасность
title Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
title_full Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
title_fullStr Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
title_full_unstemmed Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
title_short Benefits of a calcium antagonist, nifedipine GITS, in arterial hypertension treatment
title_sort benefits of a calcium antagonist nifedipine gits in arterial hypertension treatment
topic сердечно-сосудистые заболевания
антагонисты кальция
нифедипин гитс
эффективность и безопасность
url https://cardiovascular.elpub.ru/jour/article/view/1634
work_keys_str_mv AT vbmychka benefitsofacalciumantagonistnifedipinegitsinarterialhypertensiontreatment
AT iechazova benefitsofacalciumantagonistnifedipinegitsinarterialhypertensiontreatment